相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations
Dmitri Mouradov et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer
Helen Angel et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Is the lymph node ratio superior to the Union for International Cancer Control (UICC) TNM system in prognosis of colon cancer?
Leif Schiffmann et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)
FoxP3- and CD8-positive Infiltrating Immune Cells Together Determine Clinical Outcome in Colorectal Cancer
Eliane C. M. Zeestraten et al.
CANCER MICROENVIRONMENT (2013)
Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer
E. C. M. Zeestraten et al.
BRITISH JOURNAL OF CANCER (2012)
Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial
A. Tikidzhieva et al.
BRITISH JOURNAL OF CANCER (2012)
HLA-G1 and HLA-G5 active dimers are present in malignant cells and effusions: The influence of the tumor microenvironment
Sonia Zilberman et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Reassessment of HLA-G isoform specificity of MEM-G/9 and 4H84 monoclonal antibodies
L. Zhao et al.
TISSUE ANTIGENS (2012)
Natural Innate and Adaptive Immunity to Cancer
Matthew D. Vesely et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes
Fangfang Liu et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
2011: the immune hallmarks of cancer
Federica Cavallo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer
Sylvain Ladoire et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Intratumoral CD8+ T/FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer
Hiroyuki Suzuki et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Accumulation of Foxp3+ T Regulatory Cells in Draining Lymph Nodes Correlates with Disease Progression and Immune Suppression in Colorectal Cancer Patients
Liufu Deng et al.
CLINICAL CANCER RESEARCH (2010)
The Predictive Value of HLA Class I Tumor Cell Expression and Presence of Intratumoral Tregs for Chemotherapy in Patients with Early Breast Cancer
Esther M. de Kruijf et al.
CLINICAL CANCER RESEARCH (2010)
HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients
Esther M. de Kruijf et al.
JOURNAL OF IMMUNOLOGY (2010)
Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review
Katsuhiko Nosho et al.
JOURNAL OF PATHOLOGY (2010)
Immunomodulation of FOXP3+ Regulatory T Cells by the Aromatase Inhibitor Letrozole in Breast Cancer Patients
Daniele Generali et al.
CLINICAL CANCER RESEARCH (2009)
Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer
Paul Salama et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating Foxp3+ regulatory T cells
Sylvain Ladoire et al.
CLINICAL CANCER RESEARCH (2008)
HLA-E:: Strong association with β2-microglobulin and surface expression in the absence of HLA class I signal sequence-derived peptides
Elisa Lo Monaco et al.
JOURNAL OF IMMUNOLOGY (2008)
Expression of HLA-G is associated with prognosis on esophageau squamous cell carcinoma
Shang-mian Yie et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
Immune-refractory cancers and their little helpers - An extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?
Joerg Wischhusell et al.
SEMINARS IN CANCER BIOLOGY (2007)
Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer
Shang-Mian Yie et al.
LUNG CANCER (2007)
Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature
Jonathan A. Hill et al.
IMMUNITY (2007)
Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma
Shang-Mian Yie et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
Qiang Gao et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Immune surveillance of tumors
Jeremy B. Swann et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Tregs and rethinking cancer immunotherapy
Tyler J. Curiel
JOURNAL OF CLINICAL INVESTIGATION (2007)
HLA expression and cancer - 14th IHIWS immunohistochemistry quality control exercise exchange results
S. F. Chew et al.
TISSUE ANTIGENS (2007)
Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer
Shang-rong Ye et al.
MODERN PATHOLOGY (2007)
HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression
Jan Willem F. Dierssen et al.
BMC CANCER (2007)
HLA-A, -B, -C expression in colon carcinoma mimics that of the normal colonic mucosa and is prognostically relevant
Maria Benevolo et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Tumor infiltrating FOXP3+ regulatory T-cells are associated with recurrence in pathologic stage INSCLC patients
Rebecca P. Petersen et al.
CANCER (2006)
In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer
Christoph Loddenkemper et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2006)
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse
Gaynor J. Bates et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Interferons, immunity and cancer immunoediting
Gavin P. Dunn et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Cancer despite immunosurveillance: immunoselection and immunosubversion
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinorna and its premalignant lesions
Nobuyoshi Hiraoka et al.
CLINICAL CANCER RESEARCH (2006)
Intra-tumoural regulatory T cells: A potential new target in cancer immunotherapy
DJ Needham et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis
NFS Watson et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Natural killer cells infiltrating colorectal cancer and MHC class I expression
MH Sandel et al.
MOLECULAR IMMUNOLOGY (2005)
HLA-E surface expression is independent of the availability of HLA class I signal sequence-derived peptides in human tumor cell lines
GL Palmisano et al.
HUMAN IMMUNOLOGY (2005)
Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis
AG Menon et al.
LABORATORY INVESTIGATION (2004)
The 4H84 monoclonal antibody detecting β2m free nonclassical HLA-G molecules also binds to free heavy chains of classical HLA class I antigens present on activated lymphocytes
K Poláková et al.
HUMAN IMMUNOLOGY (2004)
CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
F Ghiringhelli et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
The immunobiology of cancer immunosurveillance and immunoediting
GP Dunn et al.
IMMUNITY (2004)
The three Es of cancer immunoediting
GP Dunn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
β2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide
F Perosa et al.
JOURNAL OF IMMUNOLOGY (2003)
Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: New tools to analyze the expression of nonclassical HLA class I molecules
C Menier et al.
HUMAN IMMUNOLOGY (2003)
Down-regulation of HLA-A expression correlates with a better prognosis in colorectal cancer patients
AG Menon et al.
LABORATORY INVESTIGATION (2002)
Natural selection of tumor variants in the generation of tumor escape phenotypes
HT Khong et al.
NATURE IMMUNOLOGY (2002)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
分享论文
